Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Daniel B. Putterman"'
Autor:
M. Patrick Feeney, Kim S. Schairer, Daniel B. Putterman, Angela C. Garinis, Jay J. Vachhani, Douglas H. Keefe, Denis F. Fitzpatrick, Elizabeth Kolberg
Publikováno v:
Ear & Hearing.
Publikováno v:
Am J Audiol
Purpose Individuals with cystic fibrosis (CF) are often treated with intravenous (IV) aminoglycoside (AG) antibiotics to manage life-threatening bacterial infections. Preclinical animal data suggest that, in addition to damaging cochlear hair cells,
Autor:
Douglas H. Keefe, Elizabeth Kolberg, Denis F. Fitzpatrick, Daniel B. Putterman, M. Patrick Feeney, Kim S. Schairer, Angela C. Garinis
Publikováno v:
Ear & Hearing. 43:370-378
Acoustic stapedius reflex threshold (ART) tests are included in a standard clinical acoustic immittance test battery as an objective cross-check with behavioral results and to help identify site of lesion. In traditional clinical test batteries, midd
Autor:
Angela C. Garinis, Douglas H. Keefe, Marcin Wróblewski, Lisa L. Hunter, Denis F. Fitzpatrick, Daniel B. Putterman, M. Patrick Feeney, Chelsea M. Blankenship
Publikováno v:
Hearing Research. 371:117-139
Transient-evoked otoacoustic emissions (TEOAEs) at high frequencies are a non-invasive physiological test of basilar membrane mechanics at the basal end, and have clinical potential to detect risk of hearing loss related to outer-hair-cell dysfunctio
Autor:
Angela C. Garinis, Daniel B. Putterman, M. Patrick Feeney, Denis F. Fitzpatrick, Douglas H. Keefe, Lisa L. Hunter
Publikováno v:
Ear Hear
OBJECTIVE: Wideband absorbance and absorbed power were evaluated in a group of subjects with surgically confirmed otosclerosis (Oto group), mean age 51.6 years. This is the first use of absorbed power in the assessment of middle ear disorders. Result
Autor:
Lisa L. Hunter, Angela C. Garinis, Denis F. Fitzpatrick, M. Patrick Feeney, Jeffrey A. Gold, Daniel B. Putterman, Garnett P. McMillan, Douglas H. Keefe
OBJECTIVES The goal of this study was to investigate the use of transient-evoked otoacoustic emissions (TEOAEs) and middle ear absorbance measurements to monitor auditory function in patients with cystic fibrosis (CF) receiving ototoxic medications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e50c362599e2ff29cd9c2c2af2bf714c
https://europepmc.org/articles/PMC5741529/
https://europepmc.org/articles/PMC5741529/
Autor:
Lisa L. Hunter, Daniel B. Putterman, Douglas H. Keefe, Denis F. Fitzpatrick, Garnett P. McMillan, Angela C. Garinis, M. Patrick Feeney
OBJECTIVES An important clinical application of transient-evoked otoacoustic emissions (TEOAEs) is to evaluate cochlear outer hair cell function for the purpose of detecting sensorineural hearing loss (SNHL). Double-evoked TEOAEs were measured using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ebc7004c7d00d6d407077f49c6a038
https://europepmc.org/articles/PMC5482781/
https://europepmc.org/articles/PMC5482781/
Autor:
Douglas H. Keefe, Lisa L. Hunter, Denis F. Fitzpatrick, Angela C. Garinis, M. Patrick Feeney, Daniel B. Putterman, Garnett P. McMillan
Objectives Wideband acoustic immittance (WAI) measures such as pressure reflectance, parameterized by absorbance and group delay, equivalent admittance at the tympanic membrane (TM), and acoustic stapedius reflex threshold (ASRT) describe middle ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3875f0aa1a1dbd011479ad4f8952efe9
https://europepmc.org/articles/PMC5404939/
https://europepmc.org/articles/PMC5404939/
Publikováno v:
Journal of the American Academy of Audiology. 25:462-470
Background: Wideband acoustic immittance (WAI) measures provide information about middle-ear function across the traditional audiometric frequency range from 0.25 to 8.0 kHz. Recent studies have found that WAI is effective in predicting the presence
Autor:
Angela C. Garinis, Priya Srikanth, Lisa L. Hunter, Douglas H. Keefe, Daniel B. Putterman, David M. Cohen, M. Patrick Feeney, Jeffrey A. Gold, Peter S. Steyger, Kelly Carroll, Campbell P. Cross
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 16(3)
Background Aminoglycosides (AGs) and glycopeptides are antibiotics essential for treating life-threatening respiratory infections in patients with cystic fibrosis (CF). The goal of this study was to examine the effects of cumulative intravenous (IV)-